Literature DB >> 22162552

Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses.

Gonzalo Yebra1, Miguel de Mulder, Leticia Martín, Carmen Rodríguez, Pablo Labarga, Isabel Viciana, Juan Berenguer, María Remedios Alemán, Juan Antonio Pineda, Federico García, Africa Holguín.   

Abstract

HIV-1 group M is classified into 9 subtypes, as well as recombinants favored by coinfection and superinfection events with different variants. Although HIV-1 subtype B is predominant in Europe, intersubtype recombinants are increasing in prevalence and complexity. In this study, phylogenetic analyses of pol sequences were performed to detect the HIV-1 circulating and unique recombinant forms (CRFs and URFs, respectively) in a Spanish cohort of antiretroviral treatment-naïve HIV-infected patients included in the Research Network on HIV/AIDS (CoRIS). Bootscanning and other methods were used to define complex recombinants not assigned to any subtype or CRF. A total of 670 available HIV-1 pol sequences from different patients were collected, of which 588 (87.8%) were assigned to HIV-1 subtype B and 82 (12.2%) to HIV-1 non-B variants. Recombinants caused the majority (71.9%) of HIV-1 non-B infections and were found in 8.8% of CoRIS patients. Eleven URFs (accounting for 13.4% of HIV-1 non-B infections), presenting complex mosaic patterns, were detected. Among them, 10 harbored subtype B fragments. Four of the 11 URFs were found in Spanish natives. A cluster of three B/CRF02_AG recombinants was detected. We conclude that complex variants, including unique recombinant forms, are being introduced into Spain through both immigrants and natives. An increase in the frequency of mosaic viruses, reflecting the increasing heterogeneity of the HIV epidemic in our country, is expected.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22162552      PMCID: PMC3264155          DOI: 10.1128/JCM.05798-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  52 in total

1.  HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003.

Authors:  E Lospitao; A Alvarez; V Soriano; A Holguín
Journal:  HIV Med       Date:  2005-09       Impact factor: 3.180

2.  Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.

Authors:  Joke Snoeck; Rami Kantor; Robert W Shafer; Kristel Van Laethem; Koen Deforche; Ana Patricia Carvalho; Brian Wynhoven; Marcelo A Soares; Patricia Cane; John Clarke; Candice Pillay; Sunee Sirivichayakul; Koya Ariyoshi; Africa Holguin; Hagit Rudich; Rosangela Rodrigues; Maria Belen Bouzas; Françoise Brun-Vézinet; Caroline Reid; Pedro Cahn; Luis Fernando Brigido; Zehava Grossman; Vincent Soriano; Wataru Sugiura; Praphan Phanuphak; Lynn Morris; Jonathan Weber; Deenan Pillay; Amilcar Tanuri; Richard P Harrigan; Ricardo Camacho; Jonathan M Schapiro; David Katzenstein; Anne-Mieke Vandamme
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment naïve HIV-infected individuals (CoRIS).

Authors:  Federico García; Santiago Pérez-Cachafeiro; Vicente Guillot; Marta Alvarez; Pilar Pérez-Romero; María Jesús Pérez-Elías; Isabel Viciana; Jose Ramón Blanco; Maria López-Dieguez; Carmen de Mendoza
Journal:  Antiviral Res       Date:  2011-05-30       Impact factor: 5.970

4.  Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots.

Authors:  Jianling Zhuang; Amanda E Jetzt; Guoli Sun; Hong Yu; George Klarmann; Yacov Ron; Bradley D Preston; Joseph P Dougherty
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Differences in the length of gag proteins among different HIV type 1 subtypes.

Authors:  Africa Holguín; Amparo Alvarez; Vincent Soriano
Journal:  AIDS Res Hum Retroviruses       Date:  2005-10       Impact factor: 2.205

6.  HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors.

Authors:  Masanobu Kinomoto; Regina Appiah-Opong; J A M Brandful; Masaru Yokoyama; Nicholas Nii-Trebi; Evelyn Ugly-Kwame; Hironori Sato; David Ofori-Adjei; Takeshi Kurata; Françoise Barre-Sinoussi; Tetsutaro Sata; Kenzo Tokunaga
Journal:  Clin Infect Dis       Date:  2005-06-08       Impact factor: 9.079

7.  High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance.

Authors:  Lucía Pérez-Alvarez; Rocío Carmona; Mercedes Muñoz; Elena Delgado; Michael M Thomson; Gerardo Contreras; José D Pedreira; Rafael Rodríguez Real; Elena Vázquez de Parga; Leandro Medrano; José Antonio Taboada; Rafael Nájera
Journal:  Antivir Ther       Date:  2003-08

8.  Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.

Authors:  Annemarie M J Wensing; David A van de Vijver; Gioacchino Angarano; Birgitta Asjö; Claudia Balotta; Enzo Boeri; Ricardo Camacho; Maire-Laure Chaix; Dominique Costagliola; Andrea De Luca; Inge Derdelinckx; Zehava Grossman; Osamah Hamouda; Angelos Hatzakis; Robert Hemmer; Andy Hoepelman; Andrzej Horban; Klaus Korn; Claudia Kücherer; Thomas Leitner; Clive Loveday; Eilidh MacRae; Irina Maljkovic; Carmen de Mendoza; Laurence Meyer; Claus Nielsen; Eline L Op de Coul; Vidar Ormaasen; Dimitris Paraskevis; Luc Perrin; Elisabeth Puchhammer-Stöckl; Lidia Ruiz; Mika Salminen; Jean-Claude Schmit; Francois Schneider; Rob Schuurman; Vincent Soriano; Grzegorz Stanczak; Maja Stanojevic; Anne-Mieke Vandamme; Kristel Van Laethem; Michela Violin; Karin Wilbe; Sabine Yerly; Maurizio Zazzi; Charles A Boucher
Journal:  J Infect Dis       Date:  2005-08-15       Impact factor: 5.226

9.  Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir.

Authors:  Zehava Grossman; Ellen E Paxinos; Diana Averbuch; Shlomo Maayan; Neil T Parkin; Dan Engelhard; Margalit Lorber; Valery Istomin; Yael Shaked; Ella Mendelson; Daniela Ram; Chris J Petropoulos; Jonathan M Schapiro
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

10.  Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype.

Authors:  Ashwin Vasan; Boris Renjifo; Ellen Hertzmark; Beth Chaplin; Gernard Msamanga; Max Essex; Wafaie Fawzi; David Hunter
Journal:  Clin Infect Dis       Date:  2006-02-09       Impact factor: 9.079

View more
  15 in total

1.  Molecular Epidemiology of HIV-1 Virus in Puerto Rico: Novel Cases of HIV-1 Subtype C, D, and CRF-24BG.

Authors:  Pablo López; Omayra De Jesús; Yasuhiro Yamamura; Nayra Rodríguez; Andrea Arias; Raphael Sánchez; Yadira Rodríguez; Vivian Tamayo-Agrait; Wilfredo Cuevas; Vanessa Rivera-Amill
Journal:  AIDS Res Hum Retroviruses       Date:  2018-05-23       Impact factor: 2.205

Review 2.  Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions.

Authors:  Bluma Brenner; Mark A Wainberg; Michel Roger
Journal:  AIDS       Date:  2013-04-24       Impact factor: 4.177

3.  Recent Transmission Clustering of HIV-1 C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central Italy.

Authors:  Lavinia Fabeni; Claudia Alteri; Nicoletta Orchi; Caterina Gori; Ada Bertoli; Federica Forbici; Francesco Montella; Alfredo Pennica; Gabriella De Carli; Massimo Giuliani; Fabio Continenza; Carmela Pinnetti; Emanuele Nicastri; Francesca Ceccherini-Silberstein; Claudio Maria Mastroianni; Enrico Girardi; Massimo Andreoni; Andrea Antinori; Maria Mercedes Santoro; Carlo Federico Perno
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

4.  Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012).

Authors:  Juan Ambrosioni; Omar Sued; David Nicolas; Marta Parera; María López-Diéguez; Anabel Romero; Fernando Agüero; María Ángeles Marcos; Christian Manzardo; Laura Zamora; Manuel Gómez-Carrillo; José María Gatell; Tomás Pumarola; José María Miró
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

5.  HIV-1 diversity, transmission dynamics and primary drug resistance in Angola.

Authors:  Inês Bártolo; Suzana Zakovic; Francisco Martin; Claudia Palladino; Patrícia Carvalho; Ricardo Camacho; Sven Thamm; Sofia Clemente; Nuno Taveira
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

6.  High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.

Authors:  Miguel de Mulder; Gonzalo Yebra; Adriana Navas; María Isabel de José; María Dolores Gurbindo; María Isabel González-Tomé; María José Mellado; Jesús Saavedra-Lozano; María Ángeles Muñoz-Fernández; Santiago Jiménez de Ory; José Tomás Ramos; Africa Holguín
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

7.  Description of HIV-1 group M molecular epidemiology and drug resistance prevalence in Equatorial Guinea from migrants in Spain.

Authors:  Gonzalo Yebra; Miguel de Mulder; África Holguín
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

8.  Reconstructing the timing and dispersion routes of HIV-1 subtype B epidemics in the Caribbean and Central America: a phylogenetic story.

Authors:  Israel Pagán; Africa Holguín
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

9.  New findings in cleavage sites variability across groups, subtypes and recombinants of human immunodeficiency virus type 1.

Authors:  Esther Torrecilla; Teresa Llácer Delicado; África Holguín
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

10.  HIV-1 Genetic Variability and Clinical Implications.

Authors:  Maria Mercedes Santoro; Carlo Federico Perno
Journal:  ISRN Microbiol       Date:  2013-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.